PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 128 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $862,785 | +1597650.0% | 24,900 | +1210.5% | 0.00% | – |
Q1 2024 | $54 | -1.8% | 1,900 | -20.8% | 0.00% | – |
Q4 2023 | $55 | -72.5% | 2,400 | -80.0% | 0.00% | -100.0% |
Q3 2023 | $200 | -69.4% | 12,000 | -49.4% | 0.00% | -66.7% |
Q2 2023 | $654 | -50.1% | 23,700 | -58.4% | 0.00% | +50.0% |
Q1 2023 | $1,310 | +689.2% | 57,000 | +272.5% | 0.00% | +100.0% |
Q4 2022 | $166 | -99.9% | 15,300 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $128,000 | +5.8% | 15,300 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $121,000 | -59.7% | 15,300 | +20.5% | 0.00% | 0.0% |
Q1 2022 | $300,000 | -33.5% | 12,700 | -3.8% | 0.00% | -50.0% |
Q4 2021 | $451,000 | +93.6% | 13,200 | 0.0% | 0.00% | +100.0% |
Q3 2021 | $233,000 | -40.9% | 13,200 | +50.0% | 0.00% | 0.0% |
Q2 2021 | $394,000 | +52.1% | 8,800 | -12.0% | 0.00% | 0.0% |
Q1 2021 | $259,000 | +28.9% | 10,000 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $201,000 | -42.4% | 10,000 | -49.5% | 0.00% | -50.0% |
Q2 2020 | $349,000 | +181.5% | 19,800 | +12.5% | 0.00% | +100.0% |
Q1 2020 | $124,000 | 0.0% | 17,600 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $124,000 | +5.1% | 17,600 | +27.5% | 0.00% | 0.0% |
Q1 2018 | $118,000 | +140.8% | 13,800 | +475.0% | 0.00% | – |
Q4 2017 | $49,000 | +16.7% | 2,400 | 0.0% | 0.00% | – |
Q3 2017 | $42,000 | +55.6% | 2,400 | 0.0% | 0.00% | – |
Q2 2017 | $27,000 | -10.0% | 2,400 | 0.0% | 0.00% | – |
Q1 2017 | $30,000 | -42.3% | 2,400 | 0.0% | 0.00% | – |
Q4 2016 | $52,000 | +4.0% | 2,400 | 0.0% | 0.00% | – |
Q3 2016 | $50,000 | – | 2,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Johnson & Johnson Innovation - JJDC, Inc. | 2,449,183 | $43,253,000 | 8.50% |
BVF INC/IL | 2,367,288 | $41,806,000 | 2.58% |
RTW INVESTMENTS, LP | 3,383,208 | $59,747,000 | 1.68% |
Novo Holdings A/S | 824,169 | $14,555,000 | 0.94% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,013,495 | $17,898,000 | 0.52% |
Sofinnova Investments, Inc. | 326,064 | $5,758,000 | 0.36% |
FARALLON CAPITAL MANAGEMENT LLC | 2,500,000 | $44,150,000 | 0.35% |
Virtus ETF Advisers LLC | 21,639 | $382,000 | 0.18% |
Baker Brothers Advisors | 1,911,446 | $33,756,000 | 0.15% |
King Wealth Management Group | 22,000 | $389,000 | 0.11% |